Whittemore Tingley has been appointed chief medical officer of Tenaya Therapeutics. Tingley comes to the South San Francisco, CA, biotech from Cytokinetics (NASDAQ: [[ticker:CYTK]]), where he was vice president of clinical research, cardiology. Tenaya spun out of the nonprofit Gladstone Institutes in 2016 to develop regenerative medicine treatments for heart failure.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
